Ocugen, Inc.
Biological Products, (No Diagnostic Substances) · Malvern, PA, United States
- PrincipalsRamesh RamachandranChief Accounting OfficerShankar MusunuriChief Executive OfficerTreerita Essalima Johnson-GreeneChief Financial Officer
- CompanyOcugen, Inc.Malvern, PA, United States
- Phone line+1 (484) 328-4701General business
Ocugen, Inc. is an SEC-registered Nasdaq-listed company (ticker OCGN) classified under SIC 2836: Biological Products, (No Diagnostic Substances).
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions
People 3
Chief executive
Shankar MusunuriChief Executive Officer
Finance
Ramesh RamachandranChief Accounting Officer
Treerita Essalima Johnson-GreeneChief Financial Officer
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Treerita Essalima Johnson-Greene — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Ramesh Ramachandran — Chief Accounting Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Shankar Musunuri — Chief Executive Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Pl. VIIAdaptimmune Therapeutics PLCBiological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire1 shared capabilityPl. VIIenGene Therapeutics Inc.Biological Products, (No Diagnostic Substances) · Saint-Laurent1 shared capabilityPl. VIICrispr Therapeutics AGBiological Products, (No Diagnostic Substances) · Zug1 shared capabilityPl. VIIPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityPl. VIIEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capabilityPl. VIIDBV Technologies S.A.Biological Products, (No Diagnostic Substances) · Chatillon1 shared capabilityPl. VIIChemomab Therapeutics Ltd.Pharmaceutical Preparations · Tel Aviv1 shared capabilityPl. VIIBeOne Medicines Ltd.Pharmaceutical Preparations · Basel1 shared capability